The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — ...
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
Consumer spending snapped back in August after a brief lull, adding to mounting evidence of an acceleration in the U.S.
While investors worry a spike in global bond yields will drag U.S. equities into correction territory, strategists at BofA ...
The carnage in real-estate stocks wasn't letting up on Wednesday as selling in long-dated Treasurys kept yields climbing to ...
JPMorgan has devised a TACO barometer, referring to the expression Trump Always Chickens Out ,as a way to predict the ...
A coalition of carmakers says that in nine months, it has doubled the number of charging ports it offers — although its ...
Analysts will be closely watching Micron's gross margin as a gauge of the company's pricing power. Gross margins measure the ...
So much for a scary September for the stock market. Tech stocks, including semiconductor chip names, helped the S&P 500 move ...
A prominent economist doesn’t fear artificial intelligence, but fully embraces it in portfolios. He feels far differently ...
Investors have become accustomed to returns distorted by artificially low interest rates. 5% on bonds and 6% on stocks are ...
Micron hasn't been able to buy back its stock recently, but soon that could change. Analysts note that later this year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results